Phone:  +1 607 538 2000
Fax:  +1 607 538 2511
Web Site:  www.pharmaceuticals.mallinckrodt.com/outsourcing
                 Press Releases

COMPANY BACKGROUND

Mallinckrodt, a company with a long history and wide range of pharmaceutical manufacturing experience, and its former parent company Tyco Healthcare are now Covidien.

Covidien is a global healthcare products company that manufactures, distributes and services a diverse range of industry-leading product lines, including pharmaceutical products, medical devices/ supplies, diagnostic imaging agents, and other healthcare products and services.  With 2006 revenue of nearly $10 billion, Covidien’s products and services are sold in more than 130 countries.

NUMBER OF EMPLOYEES
Worldwide 43,000, with over 3,000 in the Pharmaceutical
Products segment

KEY PERSONNEL
Daniel F. Casey, General Manager
Covidien Pharmaceuticals Outsourcing
Dale Dyer, Marketing Manager
Covidien Pharmaceuticals Outsourcing

COMPANY DESCRIPTION
Covidien Pharmaceuticals Outsourcing is focused on providing the most responsive and flexible service in the industry.  The goal is simply to be first in class. As part of Covidien, the contract manufacturing business is better positioned than ever to provide customers with effective strategies and superior service to meet production goals, timelines, and budgets.  Covidien Pharmaceuticals Outsourcing is a leader in developing and manufacturing high-quality solid dose and oral liquid finished dosage products from API production through to commercial launch.  Additionally, through a new industry alliance, the company is now able to offer services including formulation development and clinical trial services.

Covidien Pharmaceuticals Outsourcing is a leader in operational excellence programs such as lean manufacturing and Six Sigma, ensuring that products are manufactured efficiently to maintain cost. Moreover, its Hobart, N.Y., cGMP facility is DEA schedule I through V-compliant.

With strong financial resources for growth, unmatched technical expertise, and deep regulatory knowledge, Covidien Pharmaceuticals Outsourcing is a partner that can give your project the high level of attention and accountability it deserves.

MAJOR MARKETS
Covidien is a global company with products and services sold in more than 130 countries.  Covidien Pharmaceuticals Outsourcing has experience working with a diverse clientele, ranging from leading global companies to virtual and emerging entities. The company has a demonstrated record with the FDA as well as with customers, many who have outsourced with the company for more than 20 years.

MAJOR PRODUCTS/SERVICES
Our expert professionals are able to take your project from API sourcing to commercial launch.

MAJOR CAPABILITIES INCLUDE:
     •  Solid dose Tablets: Immediate Release, Extended Release
     •  Hard Shell Capsules: IR, ER, Liquid, Powder, Beads, Overencapsulation, Tablet
        within a Capsule
     • Oral Non-Sterile Liquids

MAJOR MANUFACTURING SERVICES INCLUDE:
•  Bulk API
•  Process Development
•  Analytical Method Development and Validation
•  Clinical Trial Materials Manufacturing
•  Technical Transfer, Scale-Up and Validation
•  QA/QC & Stability Testing Programs
•  Regulatory Consultation/Submission (IND, NDA, ANDA)
•  Commercial Scale-Up and Validation
•  Commercial Manufacturing (DEA Compliant)
•  Commercial Packaging (Bottles and Unit Dose Blister with Bar Coding